Skip to main content

Table 2 Metabolic syndrome prevalence, serum CRP levels and carotid intima-media thickness in the study population

From: Metabolic syndrome and carotid intima-media thickness in chronic obstructive pulmonary disease

 

COPD group

Control group

p

(n = 50)

(n = 40)

 MetS prevalence (n,%)

22 (44%)

12 (30%)

0.17

 Serum CRP (mg/dl) (median-IQR)

2.22-5.43

1.08-3.42

0.371

 Carotid IMT (mm) (mean ± SD)

1.07 ± 0.25

0.86 ± 0.18

0.001

  1. COPD Chronic obstructive pulmonary disease, CRP C reactive protein, IMT Intima- media thickness, MetS Metabolic syndrome.